Treatment for mitochondrial disorders

Grants

Funding Acknowledgements

With thanks to the staff of University of British Columbia libraries. PFC is a Wellcome Trust Senior Fellow in Clinical Science and a UK NIHR Senior Investigator who also receives funding from the Medical Research Council (UK), the Association Francaise contre les Myopathies, and the UK NIHR Biomedical Research Centre for Ageing and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust.The editorial base of the Cochrane Neuromuscular Disease Group is supported by the MRC Centre for Neuromuscular Diseases and the Muscular Dystrophy Campaign.Kari Majamaa: has received funding for travel from Octapharma and Lundbeck and speaker honoraria from OrionPharma.Douglass Turnbull: our work was supported by The Wellcome Trust Centre for Mitochondrial Research (906919), the Newcastle University Centre for Brain Ageing and Vitality supported by BBSRC, EPSRC, ESRC and MRC as part of the cross-council Lifelong Health and Wellbeing Initiative (G0700718)External sourcesWellcome Trust, UK.Funding for PFC and DMTMuscular Dystrophy Campaign, UK.Funding for DRTMedical Research Council, UK.Funding for PFC and DMTAtaxia, UK.Association Francaise contre les myopathies, France.Funding for PFC and DMTCouncil for Health Research, Finland.Sigrid Juselius Foundation, Finland.Australian National Health and Medical Research Council, Australia.Funding for DRTMuscular Dystrophy Association, USA.Funding for DRTParkinson's UK, UK.Funding for PFC and DMTNational Institute for Health Research (NIHR), UK.Funding for PFC and DMT through the Newcastle NIHR Biomedical Research Centre in ageing and age-related disease